Related Experiment Video
Updated: Nov 26, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Targeting transcriptional coregulator OCA-B/Pou2af1 blocks activated autoreactive T cells in the pancreas and type 1
Heejoo Kim1,2, Jelena Perovanovic1,2, Arvind Shakya1
1Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT.
Abstract:
The transcriptional coregulator OCA-B promotes expression of T cell target genes in cases of repeated antigen exposure, a necessary feature of autoimmunity. We hypothesized that T cell-specific OCA-B deletion and pharmacologic OCA-B inhibition would protect mice from autoimmune diabetes. We developed an Ocab conditional allele and backcrossed it onto a diabetes-prone NOD/ShiLtJ strain background. T cell-specific OCA-B loss protected mice from spontaneous disease. Protection was associated with large reductions in islet CD8+ T cell receptor specificities associated with diabetes pathogenesis. CD4+ clones associated with diabetes were present but associated with anergic phenotypes. The protective effect of OCA-B loss was recapitulated using autoantigen-specific NY8.3 mice but diminished in monoclonal models specific to artificial or neoantigens. Rationally designed membrane-penetrating OCA-B peptide inhibitors normalized glucose levels and reduced T cell infiltration and proinflammatory cytokine expression in newly diabetic NOD mice. Together, the results indicate that OCA-B is a potent autoimmune regulator and a promising target for pharmacologic inhibition.
Insights
Targeting the transcriptional coregulator OCA-B (OCAB) in T cells can prevent autoimmune diabetes in mice. Pharmacologic inhibition of OCA-B also shows promise for treating this condition.
Area of Science:
- Immunology
- Molecular Biology
- Endocrinology
Background:
- Autoimmune diseases like diabetes involve T cell-mediated attacks on self-tissues.
- The transcriptional coregulator OCA-B (OCAB) is implicated in T cell activation and gene expression.
Purpose of the Study:
- To investigate the role of OCA-B in autoimmune diabetes pathogenesis.
- To determine if targeting OCA-B can prevent or treat autoimmune diabetes.
Main Methods:
- Generated T cell-specific OCA-B knockout mice on a diabetes-prone background (NOD/ShiLtJ).
- Utilized autoantigen-specific mouse models (NY8.3) and monoclonal antigen models.
- Administered rationally designed OCA-B peptide inhibitors to diabetic mice.
Main Results:
- T cell-specific deletion of OCA-B protected mice from spontaneous autoimmune diabetes.
- OCA-B loss reduced pathogenic CD8+ T cell specificities and induced anergic phenotypes in CD4+ T cells.
- OCA-B peptide inhibitors normalized glucose levels and reduced inflammation in diabetic mice.
Conclusions:
- OCA-B is a critical regulator of autoimmune diabetes.
- Targeting OCA-B, through genetic deletion or pharmacologic inhibition, represents a potential therapeutic strategy for autoimmune diabetes.
More Related Videos
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
Related Concept Videos
Cell Specific Gene Expression
Psychoneuroimmunology: Diabetes and Cancer
Co-activators and Co-repressors
Co-activators and Co-repressors
RNA Polymerase II Accessory Proteins
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...